212 related articles for article (PubMed ID: 18284271)
1. The costs of schizophrenia.
McEvoy JP
J Clin Psychiatry; 2007; 68 Suppl 14():4-7. PubMed ID: 18284271
[TBL] [Abstract][Full Text] [Related]
2. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
Phanthunane P; Whiteford H; Vos T; Bertram M
J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
[TBL] [Abstract][Full Text] [Related]
3. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
4. The functionality and economic costs of outpatients with schizophrenia in Taiwan.
Lee IH; Chen PS; Yang YK; Liao YC; Lee YD; Yeh TL; Yeh LL; Cheng SH; Chu CL
Psychiatry Res; 2008 Apr; 158(3):306-15. PubMed ID: 18243334
[TBL] [Abstract][Full Text] [Related]
5. Outpatient antipsychotic treatment and inpatient costs of schizophrenia.
Marcus SC; Olfson M
Schizophr Bull; 2008 Jan; 34(1):173-80. PubMed ID: 17578893
[TBL] [Abstract][Full Text] [Related]
6. The economic impact of schizophrenia.
Rice DP
J Clin Psychiatry; 1999; 60 Suppl 1():4-6; discussion 28-30. PubMed ID: 10037163
[TBL] [Abstract][Full Text] [Related]
7. Economic cost of Guillain-Barré syndrome in the United States.
Frenzen PD
Neurology; 2008 Jul; 71(1):21-7. PubMed ID: 18591502
[TBL] [Abstract][Full Text] [Related]
8. The socioeconomic costs of mental illness in Spain.
Oliva-Moreno J; López-Bastida J; Montejo-González AL; Osuna-Guerrero R; Duque-González B
Eur J Health Econ; 2009 Oct; 10(4):361-9. PubMed ID: 19031056
[TBL] [Abstract][Full Text] [Related]
9. The cost of alcohol in California.
Rosen SM; Miller TR; Simon M
Alcohol Clin Exp Res; 2008 Nov; 32(11):1925-36. PubMed ID: 18717655
[TBL] [Abstract][Full Text] [Related]
10. Does public insurance provide better financial protection against rising health care costs for families of children with special health care needs?
Yu H; Dick AW; Szilagyi PG
Med Care; 2008 Oct; 46(10):1064-70. PubMed ID: 18815528
[TBL] [Abstract][Full Text] [Related]
11. Estimating the cost of epilepsy in Europe: a review with economic modeling.
Pugliatti M; Beghi E; Forsgren L; Ekman M; Sobocki P
Epilepsia; 2007 Dec; 48(12):2224-33. PubMed ID: 18088267
[TBL] [Abstract][Full Text] [Related]
12. Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective.
Birnbaum HG; White AG; Reynolds JL; Greenberg PE; Zhang M; Vallow S; Schein JR; Katz NP
Clin J Pain; 2006 Oct; 22(8):667-76. PubMed ID: 16988561
[TBL] [Abstract][Full Text] [Related]
13. Economic costs of obsessive-compulsive disorder.
DuPont RL; Rice DP; Shiraki S; Rowland CR
Med Interface; 1995 Apr; 8(4):102-9. PubMed ID: 10141765
[TBL] [Abstract][Full Text] [Related]
14. [Costs of schizophrenia - what we know (not)?].
Salize HJ
Psychiatr Prax; 2001 Jul; 28 Suppl 1():S21-8. PubMed ID: 11533903
[TBL] [Abstract][Full Text] [Related]
15. The economic burden of schizophrenia in the United States in 2002.
Wu EQ; Birnbaum HG; Shi L; Ball DE; Kessler RC; Moulis M; Aggarwal J
J Clin Psychiatry; 2005 Sep; 66(9):1122-9. PubMed ID: 16187769
[TBL] [Abstract][Full Text] [Related]
16. Australian Schizophrenia Care and Assessment Programme: real-world schizophrenia: economics.
Fitzgerald PB; Montgomery W; de Castella AR; Filia KM; Filia SL; Christova L; Jackson D; Kulkarni J
Aust N Z J Psychiatry; 2007 Oct; 41(10):819-29. PubMed ID: 17828655
[TBL] [Abstract][Full Text] [Related]
17. The burden of prenatal exposure to alcohol: revised measurement of cost.
Stade B; Ali A; Bennett D; Campbell D; Johnston M; Lens C; Tran S; Koren G
Can J Clin Pharmacol; 2009; 16(1):e91-102. PubMed ID: 19168935
[TBL] [Abstract][Full Text] [Related]
18. [Direct and indirect costs of schizophrenia].
Kissling W; Höffler J; Seemann U; Müller P; Rüther E; Trenckmann U; Uber A; Graf von der Schulenburg JM; Glaser P; Glaser T; Mast O; Schmidt D
Fortschr Neurol Psychiatr; 1999 Jan; 67(1):29-36. PubMed ID: 10065387
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
[TBL] [Abstract][Full Text] [Related]
20. Panel on cost-effectiveness in health and medicine recommendations: identifying costs.
Manning WG
J Clin Psychiatry; 1999; 60 Suppl 3():54-6; discussion 57-8. PubMed ID: 10073379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
